Fast-track diagnostics: Biocartis and Fast-track diagnostics Collaborate on Infectious Diseases

Biocartis and Fast-track diagnostics, which provides multiplex polymerase chain reaction (PCR) test kits for infectious disease, entered into a strategic collaboration to develop a range of multiplex infectious disease tests to run on the Biocartis Idylla molecular diagnostics (MDx) system.Biocartis and Fast-track diagnostics plan to use a new approach to infectious disease diagnostics called "syndromic multiplex testing," which should enable the identification of a broader range of disease pathogens in a single test. Most current methods focus on the detection of one or a few pathogens expected to be present in a patient sample. If the sample is negative, a new test will be performed for other pathogens, increasing the time to result. With syndromic multiplex tests, the initial test will not just look for the most likely pathogen, but also for a range of less likely pathogens, preventing the need to retest.As part of the collaboration, tests from Fast-track diagnos